ATE551354T1 - Modifizierte bakteriocine und verwendungsverfahren dafür - Google Patents

Modifizierte bakteriocine und verwendungsverfahren dafür

Info

Publication number
ATE551354T1
ATE551354T1 AT07797461T AT07797461T ATE551354T1 AT E551354 T1 ATE551354 T1 AT E551354T1 AT 07797461 T AT07797461 T AT 07797461T AT 07797461 T AT07797461 T AT 07797461T AT E551354 T1 ATE551354 T1 AT E551354T1
Authority
AT
Austria
Prior art keywords
bacteriocins
modified
methods
bacteria
receptors
Prior art date
Application number
AT07797461T
Other languages
English (en)
Inventor
David Martin
Andrew Jamieson
Dean Scholl
Steven Williams
Original Assignee
Avidbiotics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidbiotics Corp filed Critical Avidbiotics Corp
Application granted granted Critical
Publication of ATE551354T1 publication Critical patent/ATE551354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
AT07797461T 2006-05-15 2007-05-14 Modifizierte bakteriocine und verwendungsverfahren dafür ATE551354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74729906P 2006-05-15 2006-05-15
PCT/US2007/068908 WO2007134303A2 (en) 2006-05-15 2007-05-14 Modified bacteriocins and methods for their use

Publications (1)

Publication Number Publication Date
ATE551354T1 true ATE551354T1 (de) 2012-04-15

Family

ID=38694773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07797461T ATE551354T1 (de) 2006-05-15 2007-05-14 Modifizierte bakteriocine und verwendungsverfahren dafür

Country Status (11)

Country Link
US (1) US7732586B2 (de)
EP (2) EP2371842B1 (de)
JP (1) JP5603070B2 (de)
AT (1) ATE551354T1 (de)
AU (1) AU2007249199B2 (de)
BR (1) BRPI0711969A2 (de)
CA (1) CA2652450C (de)
DK (2) DK2021358T3 (de)
ES (2) ES2548392T3 (de)
PL (1) PL2021358T3 (de)
WO (1) WO2007134303A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007049770A1 (ja) * 2005-10-28 2009-04-30 明治製菓株式会社 緑膿菌の外膜タンパク質ｐａ５１５８
US8445639B2 (en) * 2006-05-15 2013-05-21 Avidbiotics Corporation Recombinant bacteriophage and methods for their use
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
US8680019B2 (en) * 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US20090176654A1 (en) * 2007-08-10 2009-07-09 Protelix, Inc. Universal fibronectin type III binding-domain libraries
US20110021414A1 (en) * 2007-10-24 2011-01-27 Texas A & M University System Chimeric Phage Tail Proteins and Uses Thereof
KR20140002463A (ko) * 2010-05-27 2014-01-08 아비드바이오틱스 코포레이션 디포신 및 그의 사용 방법
US9115354B2 (en) 2010-05-27 2015-08-25 Avidbiotics Corp. Diffocins and methods of use thereof
JP5808398B2 (ja) 2010-06-02 2015-11-10 ジョンズ ホプキンズ ユニバーシティＪｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ 微生物の薬物耐性を判定するシステムおよび方法
WO2015022306A1 (en) 2013-08-12 2015-02-19 Dupont Nutrition Biosciences Aps Methods for classification of microorganisms from food products
GB201416788D0 (en) * 2014-09-23 2014-11-05 Univ Glasgow Therapeutic applications for pyocins
AU2015342937B2 (en) * 2014-11-07 2019-06-06 Pylum Biosciences, Inc. Monocins and methods of use
BR112020000643A2 (pt) 2017-07-12 2020-07-14 DDP Specialty Electronic Materials US, Inc. bactéria, bacteriocina, extrato de sobrenadante parcialmente purificado, composição, e, método para controlar procariontes indesejados.
US11572595B2 (en) 2018-12-31 2023-02-07 Roche Molecular Systems, Inc. Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems
CN110129279B (zh) * 2019-04-24 2022-02-18 昆明理工大学 一种粪肠球菌噬菌体及其分离、纯化、富集和应用
JP2023528151A (ja) * 2020-04-07 2023-07-04 パイラム バイオサイエンシズ，インコーポレイティド エンテロシンおよびその使用方法
CN112083253B (zh) * 2020-09-18 2021-07-02 西南交通大学 一种直流下土壤电参量状态反演方法
WO2023178352A2 (en) * 2022-03-18 2023-09-21 Carnegie Mellon University Lysin and gp38 peptides for bacteria detection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4142939A (en) 1976-03-31 1979-03-06 Oregon State Board Of Higher Education, An Agency Of The State Of Oregon Method of producing an r-type bacteriocin and its use in the detection of specific microorganisms
US4861754A (en) 1986-05-28 1989-08-29 Farkas Himsley Hannah Bacteriocins and compositions thereof in anti-viral treatment
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
HUP0100668A3 (en) 1997-11-25 2005-01-28 Gen Hospital Corp Boston Virulence-associated nucleic sequences and uses thereof
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
WO2000060070A1 (en) 1999-04-01 2000-10-12 Innogenetics N.V. A polypeptide structure for use as a scaffold
WO2001001786A2 (en) * 1999-07-06 2001-01-11 Friesland Brands B.V. Methods and means for producing improved dairy products
US7034113B2 (en) 2002-02-22 2006-04-25 Paradigm Diagnostics, Llc Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
WO2005046579A2 (en) 2003-10-06 2005-05-26 Gangagen, Inc. Defined dose therapeutic phage
CN101090967A (zh) 2004-08-03 2007-12-19 加利福尼亚大学董事会 产多形性蛋白质序列的位点特异性系统
US20060229244A1 (en) * 2004-09-27 2006-10-12 Robert Dorit Engineered bacteriocins and bacteriocin combinations and methods for treating bacterial based infections

Also Published As

Publication number Publication date
CA2652450C (en) 2013-10-15
AU2007249199A1 (en) 2007-11-22
BRPI0711969A2 (pt) 2012-01-24
JP2009537146A (ja) 2009-10-29
WO2007134303A3 (en) 2008-03-13
EP2371842A1 (de) 2011-10-05
WO2007134303A2 (en) 2007-11-22
US20080113406A1 (en) 2008-05-15
ES2387722T3 (es) 2012-09-28
PL2021358T3 (pl) 2012-09-28
EP2021358B1 (de) 2012-03-28
CA2652450A1 (en) 2007-11-22
ES2548392T3 (es) 2015-10-16
EP2021358A2 (de) 2009-02-11
DK2371842T3 (en) 2015-10-26
EP2371842B1 (de) 2015-07-22
DK2021358T3 (da) 2012-07-16
US7732586B2 (en) 2010-06-08
JP5603070B2 (ja) 2014-10-08
AU2007249199B2 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
ATE551354T1 (de) Modifizierte bakteriocine und verwendungsverfahren dafür
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
MY156458A (en) Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
WO2006085938A3 (en) Il-13 binding agents
EP1809326A4 (de) Modulation von antikörperspezifität mittels anpassung der affinität zu verwandten antigenen
WO2011039510A8 (en) Agents, uses and methods
DK2061814T3 (da) Antistoffer og immunokonjugater og anvendelse deraf.
DK1966130T3 (da) Modificerede lysin-mimetiske forbindelser
BRPI0617479A2 (pt) método e composição útil para manter ou melhorar a saúde gastrintestiinal de um animal, kit, meio para comunicação de informações ou instruções, e, uso de uma composição
BRPI0716354A2 (pt) "composiÇço e mÉtodo"
ATE445325T1 (de) Ölsuspensionskonzentrat
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
JP2009521520A5 (de)
IL206036A0 (en) ANTIBODIES TO THE PcrV ANTIGEN OF PSEUDOMONAS AERUGINOSA AND USES THEREOF
WO2008150485A3 (en) Erbb2 binding proteins and use thereof
BR112013011193A2 (pt) bacteriófago p4 recombinante e métodos para seu uso
EP2362862A4 (de) Modifiziertes schwefelbindemittel und herstellungsverfahren dafür, hydraulische modifizierten schwefel enthaltende stoffzusammensetzung und herstellungsverfahren dafür oder brennbare modifizierten schwefel enthaltende stoffzusammensetzung und herstellungsverfahren dafür, enthaltend das modifizierte schwefelbindemittel
JP2008542528A5 (de)
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
WO2007030761A3 (en) Acyclic 1,4-diamines and uses thereof
WO2009055074A3 (en) Erbb2 binding proteins and use thereof
ATE488255T1 (de) Antimikrobielle zusammensetzung
ATE517642T1 (de) Kombination zum verkleben von biologischen geweben
IL190045A0 (en) Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents